| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion channel activity | PIEZO1 PKD1L1 GRIK2 ANO10 RYR3 PIEZO2 TRPM5 SCN2A SCN3A SCN9A LRRC8B GABRA1 GABRA5 | 1.82e-06 | 459 | 112 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | PIEZO1 PKD1L1 GRIK2 ANO10 RYR3 PIEZO2 TRPM5 SCN2A SCN3A SCN9A LRRC8B GABRA1 GABRA5 | 7.83e-06 | 525 | 112 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | PIEZO1 PKD1L1 GRIK2 ANO10 RYR3 PIEZO2 TRPM5 SCN2A SCN3A SCN9A LRRC8B GABRA1 GABRA5 | 7.99e-06 | 526 | 112 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | sodium channel activity | 1.07e-05 | 52 | 112 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | PIEZO1 PKD1L1 GRIK2 ANO10 RYR3 PIEZO2 TRPM5 SCN2A SCN3A SCN9A | 2.35e-05 | 343 | 112 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC26A2 PIEZO1 PKD1L1 GRIK2 ANO10 SLC25A37 RYR3 PIEZO2 TRPM5 SCN2A SCN3A SCN9A LRRC8B GABRA1 GABRA5 | 3.67e-05 | 793 | 112 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | sodium ion binding | 5.98e-05 | 14 | 112 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 9.32e-05 | 3 | 112 | 2 | GO:0008184 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.12e-04 | 334 | 112 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.32e-04 | 18 | 112 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 2.45e-04 | 22 | 112 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | transporter activity | TMEM30B SLC26A2 PIEZO1 PKD1L1 PEX6 GRIK2 ANO10 SLC7A11 SLC25A37 RYR3 PIEZO2 TRPM5 SCN2A SCN3A SCN9A LRRC8B GABRA1 GABRA5 | 2.90e-04 | 1289 | 112 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 3.08e-04 | 5 | 112 | 2 | GO:0004645 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.19e-04 | 24 | 112 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.07e-04 | 26 | 112 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 4.07e-04 | 26 | 112 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.08e-04 | 28 | 112 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.37e-04 | 118 | 112 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.47e-04 | 70 | 112 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.73e-04 | 193 | 112 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 8.39e-04 | 75 | 112 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 8.60e-04 | 197 | 112 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC26A2 PIEZO1 PKD1L1 GRIK2 ANO10 SLC7A11 SLC25A37 RYR3 PIEZO2 TRPM5 SCN2A SCN3A SCN9A LRRC8B GABRA1 GABRA5 | 8.91e-04 | 1180 | 112 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC26A2 PKD1L1 GRIK2 ANO10 SLC25A37 RYR3 TRPM5 SCN2A SCN3A SCN9A GABRA1 GABRA5 | 1.12e-03 | 758 | 112 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.16e-03 | 37 | 112 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | PIEZO1 PKD1L1 GRIK2 ANO10 SLC25A37 RYR3 PIEZO2 TRPM5 SCN2A SCN3A SCN9A | 1.27e-03 | 664 | 112 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.62e-03 | 151 | 112 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.66e-03 | 11 | 112 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.90e-03 | 230 | 112 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | tau protein binding | 2.19e-03 | 46 | 112 | 3 | GO:0048156 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.43e-03 | 100 | 112 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.71e-03 | 103 | 112 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.78e-03 | 50 | 112 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.79e-03 | 171 | 112 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | caspase binding | 3.55e-03 | 16 | 112 | 2 | GO:0089720 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 4.03e-03 | 57 | 112 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 4.50e-03 | 18 | 112 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 4.50e-03 | 18 | 112 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 4.50e-03 | 18 | 112 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.66e-03 | 60 | 112 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.70e-03 | 465 | 112 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 5.01e-03 | 19 | 112 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.40e-03 | 125 | 112 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.83e-03 | 65 | 112 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.83e-03 | 65 | 112 | 3 | GO:0022824 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC26A2 PIEZO1 PKD1L1 SPG11 GRIK2 ANO10 ACE GEM SLC25A37 RYR3 GRAMD2A PIEZO2 TRPM5 TMEM168 SCN2A SCN3A SCN9A LRRC8B UTRN WNK3 GABRA1 GABRA5 | 4.65e-06 | 1374 | 113 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC26A2 PIEZO1 PKD1L1 GRIK2 ANO10 GEM SLC25A37 RYR3 PIEZO2 TRPM5 TMEM168 SCN2A SCN3A SCN9A LRRC8B UTRN WNK3 GABRA1 GABRA5 | 9.61e-06 | 1115 | 113 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | ADCY10 CUX2 PIEZO1 LRRK2 GRIK2 GRM1 PIEZO2 NUP155 SCN2A SCN3A SCN9A GABRA1 GABRA5 | 1.20e-05 | 559 | 113 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | ADCY10 TMEM126A FAM53A LRRK2 PEX6 SPG11 VPS25 NUP155 MKLN1 DKC1 MACF1 NUP188 | 2.59e-05 | 515 | 113 | 12 | GO:0072594 |
| GeneOntologyBiologicalProcess | intracellular protein transport | TMEM30B FAM53A LRRK2 BARD1 PEX6 SPG11 VPS25 AP1S1 NUP155 STRADA EHD1 AP1S2 NUP188 HERC2 | 5.32e-05 | 740 | 113 | 14 | GO:0006886 |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 6.83e-05 | 126 | 113 | 6 | GO:0033555 | |
| GeneOntologyBiologicalProcess | synapse organization | COL4A1 CUX2 PRMT8 MARK1 LRRK2 SPG11 PPFIA3 SLC7A11 MARK2 RAPGEF2 MDGA1 GABRA1 GABRA5 | 9.70e-05 | 685 | 113 | 13 | GO:0050808 |
| GeneOntologyBiologicalProcess | behavior | CUX2 LRRK2 SPG11 GRIK2 BRINP1 GRM1 ACE SLC7A11 SCN2A SCN3A NR2E1 SCN9A AP1S2 DNAH11 GABRA5 | 1.05e-04 | 891 | 113 | 15 | GO:0007610 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.50e-04 | 208 | 113 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.60e-04 | 93 | 113 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | PIEZO1 PKD1L1 SPG11 ANO10 ACE GEM SLC25A37 RYR3 GRAMD2A PIEZO2 TRPM5 TMEM168 SCN2A SCN3A SCN9A UTRN WNK3 | 1.84e-04 | 1157 | 113 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | cell junction organization | COL4A1 CUX2 PRMT8 MARK1 LRRK2 SPG11 PPFIA3 ACE SLC7A11 MACF1 MARK2 RAPGEF2 MDGA1 GABRA1 GABRA5 | 2.77e-04 | 974 | 113 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | behavioral fear response | 2.88e-04 | 58 | 113 | 4 | GO:0001662 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | ADCY10 TMEM126A MARK3 FAM53A LRRK2 BARD1 PEX6 SPG11 VPS25 NUP155 EHD1 MKLN1 DKC1 MACF1 NUP188 DNAH11 | 2.96e-04 | 1091 | 113 | 16 | GO:0033365 |
| GeneOntologyBiologicalProcess | behavioral defense response | 3.08e-04 | 59 | 113 | 4 | GO:0002209 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 3.08e-04 | 59 | 113 | 4 | GO:0003351 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.73e-04 | 62 | 113 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | extracellular transport | 3.73e-04 | 62 | 113 | 4 | GO:0006858 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 3.80e-04 | 112 | 113 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 3.84e-04 | 173 | 113 | 6 | GO:0009581 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 3.97e-04 | 63 | 113 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 4.09e-04 | 175 | 113 | 6 | GO:0009582 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC26A2 PKD1L1 ANO10 GEM SLC25A37 RYR3 TRPM5 TMEM168 SCN2A SCN3A SCN9A UTRN WNK3 GABRA1 GABRA5 | 4.37e-04 | 1017 | 113 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | fear response | 4.74e-04 | 66 | 113 | 4 | GO:0042596 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 4.74e-04 | 180 | 113 | 6 | GO:0060078 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 5.33e-04 | 184 | 113 | 6 | GO:0051961 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 5.38e-04 | 515 | 113 | 10 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | ADCY10 CUX2 MARK1 LRRK2 PTPN9 EHD1 NR2E1 MACF1 MARK2 RAPGEF2 CUX1 | 5.41e-04 | 612 | 113 | 11 | GO:0010975 |
| GeneOntologyBiologicalProcess | membrane depolarization | 5.42e-04 | 121 | 113 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | camera-type eye development | COL4A1 SOX11 LPCAT1 NR2E3 SLC7A11 CASZ1 ADAMTS9 NR2E1 CRYBG3 | 5.65e-04 | 426 | 113 | 9 | GO:0043010 |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 5.84e-04 | 30 | 113 | 3 | GO:1904862 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | PIEZO1 PKD1L1 ANO10 GEM SLC25A37 RYR3 PIEZO2 TRPM5 TMEM168 SCN2A SCN3A SCN9A UTRN WNK3 | 6.37e-04 | 942 | 113 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | ADCY10 SOX11 CUX2 BRINP1 ACE CASZ1 NR2E1 MACF1 RAPGEF2 MDGA1 CUX1 | 6.43e-04 | 625 | 113 | 11 | GO:0051960 |
| GeneOntologyBiologicalProcess | sensory organ development | COL4A1 SOX11 LPCAT1 NR2E3 SLC7A11 CASZ1 ADAMTS9 NR2E1 CRYBG3 USH2A CUX1 GABRA5 | 6.65e-04 | 730 | 113 | 12 | GO:0007423 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 6.75e-04 | 127 | 113 | 5 | GO:0070252 | |
| GeneOntologyCellularComponent | cell projection membrane | SLC26A2 PIEZO1 PKD1L1 ACE SLC7A11 EHD1 MACF1 USH2A UTRN WWC1 GABRA1 GABRA5 | 3.83e-06 | 431 | 113 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | sodium channel complex | 1.73e-05 | 29 | 113 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | PKD1L1 GRIK2 RYR3 TRPM5 SCN2A SCN3A SCN9A LRRC8B GABRA1 GABRA5 | 3.95e-05 | 378 | 113 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | dendrite | ADCY10 MARK1 MARK3 LRRK2 SPG11 GRIK2 BRINP1 MAGEE1 GRM1 TRPM5 BRINP2 MARK2 MDGA1 GABRA1 GABRA5 | 5.95e-05 | 858 | 113 | 15 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ADCY10 MARK1 MARK3 LRRK2 SPG11 GRIK2 BRINP1 MAGEE1 GRM1 TRPM5 BRINP2 MARK2 MDGA1 GABRA1 GABRA5 | 6.11e-05 | 860 | 113 | 15 | GO:0097447 |
| GeneOntologyCellularComponent | nuclear pore inner ring | 8.66e-05 | 3 | 113 | 2 | GO:0044611 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 9.90e-05 | 17 | 113 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ADCY10 MARK1 MARK3 LRRK2 SPG11 GRIK2 BRINP1 MAGEE1 GRM1 TRPM5 SCN3A BRINP2 MARK2 RAPGEF2 MDGA1 USH2A GABRA1 GABRA5 | 1.01e-04 | 1228 | 113 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | transporter complex | TMEM30B PKD1L1 GRIK2 RYR3 TRPM5 SCN2A SCN3A SCN9A LRRC8B GABRA1 GABRA5 | 1.95e-04 | 550 | 113 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | transmembrane transporter complex | PKD1L1 GRIK2 RYR3 TRPM5 SCN2A SCN3A SCN9A LRRC8B GABRA1 GABRA5 | 5.47e-04 | 523 | 113 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | cytoplasmic region | 7.62e-04 | 360 | 113 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | leading edge membrane | 9.91e-04 | 210 | 113 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | cation channel complex | 1.76e-03 | 235 | 113 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | terminal bouton | 1.83e-03 | 96 | 113 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | AP-1 adaptor complex | 1.85e-03 | 12 | 113 | 2 | GO:0030121 | |
| HumanPheno | Dysgenesis of the hippocampus | 1.61e-05 | 16 | 52 | 4 | HP:0025101 | |
| HumanPheno | Focal impaired awareness seizure | 3.39e-05 | 126 | 52 | 8 | HP:0002384 | |
| HumanPheno | Photosensitive myoclonic seizure | 5.42e-05 | 8 | 52 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 5.42e-05 | 8 | 52 | 3 | HP:0200048 | |
| HumanPheno | Poor fine motor coordination | 6.18e-05 | 69 | 52 | 6 | HP:0007010 | |
| HumanPheno | Tibial torsion | 7.41e-05 | 23 | 52 | 4 | HP:0100694 | |
| HumanPheno | Atypical absence seizure | 9.10e-05 | 46 | 52 | 5 | HP:0007270 | |
| HumanPheno | Focal hemiclonic seizure | 1.04e-04 | 25 | 52 | 4 | HP:0006813 | |
| HumanPheno | Abnormal hippocampus morphology | 1.12e-04 | 48 | 52 | 5 | HP:0025100 | |
| HumanPheno | Abnormal morphology of the limbic system | 1.24e-04 | 49 | 52 | 5 | HP:0007343 | |
| HumanPheno | Clonic seizure | 1.52e-04 | 81 | 52 | 6 | HP:0020221 | |
| HumanPheno | Limited neck range of motion | 1.56e-04 | 11 | 52 | 3 | HP:0000466 | |
| HumanPheno | Poor motor coordination | 1.99e-04 | 85 | 52 | 6 | HP:0002275 | |
| HumanPheno | Epilepsia partialis continua | 2.07e-04 | 12 | 52 | 3 | HP:0012847 | |
| HumanPheno | Progressive gait ataxia | 2.18e-04 | 30 | 52 | 4 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 2.18e-04 | 30 | 52 | 4 | HP:0001329 | |
| HumanPheno | Congenitally corrected transposition of the great arteries | 3.05e-04 | 3 | 52 | 2 | HP:0011540 | |
| HumanPheno | Obsessive-compulsive trait | 3.18e-04 | 33 | 52 | 4 | HP:0008770 | |
| HumanPheno | Atonic seizure | 3.45e-04 | 94 | 52 | 6 | HP:0010819 | |
| Domain | MARK/par1 | 8.36e-07 | 4 | 112 | 3 | IPR033624 | |
| Domain | KA1 | 2.08e-06 | 5 | 112 | 3 | PF02149 | |
| Domain | KA1_dom | 2.08e-06 | 5 | 112 | 3 | IPR001772 | |
| Domain | KA1 | 2.08e-06 | 5 | 112 | 3 | PS50032 | |
| Domain | - | 2.08e-06 | 5 | 112 | 3 | 3.30.310.80 | |
| Domain | Na_trans_cytopl | 4.14e-06 | 6 | 112 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 4.14e-06 | 6 | 112 | 3 | IPR024583 | |
| Domain | CUT | 7.22e-06 | 7 | 112 | 3 | PS51042 | |
| Domain | KA1/Ssp2_C | 7.22e-06 | 7 | 112 | 3 | IPR028375 | |
| Domain | CUT | 7.22e-06 | 7 | 112 | 3 | PF02376 | |
| Domain | CUT_dom | 7.22e-06 | 7 | 112 | 3 | IPR003350 | |
| Domain | CUT | 7.22e-06 | 7 | 112 | 3 | SM01109 | |
| Domain | Na_channel_asu | 2.44e-05 | 10 | 112 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 2.44e-05 | 10 | 112 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 2.44e-05 | 10 | 112 | 3 | PF06512 | |
| Domain | PIEZO | 3.56e-05 | 2 | 112 | 2 | PF15917 | |
| Domain | Piezo | 3.56e-05 | 2 | 112 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 3.56e-05 | 2 | 112 | 2 | PF12166 | |
| Domain | Piezo_RRas-bd_dom | 3.56e-05 | 2 | 112 | 2 | IPR031334 | |
| Domain | Piezo_dom | 3.56e-05 | 2 | 112 | 2 | IPR031805 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.28e-05 | 14 | 112 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.28e-05 | 14 | 112 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.28e-05 | 14 | 112 | 3 | IPR013602 | |
| Domain | DHC_N2 | 7.28e-05 | 14 | 112 | 3 | PF08393 | |
| Domain | MT | 7.28e-05 | 14 | 112 | 3 | PF12777 | |
| Domain | AAA_8 | 7.28e-05 | 14 | 112 | 3 | PF12780 | |
| Domain | DHC_fam | 9.06e-05 | 15 | 112 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 9.06e-05 | 15 | 112 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 9.06e-05 | 15 | 112 | 3 | IPR004273 | |
| Domain | PHOSPHORYLASE | 1.07e-04 | 3 | 112 | 2 | PS00102 | |
| Domain | BRINP | 1.07e-04 | 3 | 112 | 2 | IPR033237 | |
| Domain | Glycg_phsphrylas | 1.07e-04 | 3 | 112 | 2 | IPR011833 | |
| Domain | Glyco_trans_35 | 1.07e-04 | 3 | 112 | 2 | IPR000811 | |
| Domain | Phosphorylase | 1.07e-04 | 3 | 112 | 2 | PF00343 | |
| Domain | EF-hand-dom_pair | 3.37e-04 | 287 | 112 | 8 | IPR011992 | |
| Domain | GABAAa_rcpt | 5.26e-04 | 6 | 112 | 2 | IPR001390 | |
| Domain | - | 5.53e-04 | 27 | 112 | 3 | 1.10.260.40 | |
| Domain | Ion_trans_dom | 6.19e-04 | 114 | 112 | 5 | IPR005821 | |
| Domain | Ion_trans | 6.19e-04 | 114 | 112 | 5 | PF00520 | |
| Domain | Lambda_DNA-bd_dom | 6.85e-04 | 29 | 112 | 3 | IPR010982 | |
| Domain | AP_complex_ssu | 7.34e-04 | 7 | 112 | 2 | IPR016635 | |
| Domain | UBA | 7.57e-04 | 30 | 112 | 3 | SM00165 | |
| Domain | DHC_N1 | 9.75e-04 | 8 | 112 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 9.75e-04 | 8 | 112 | 2 | IPR013594 | |
| Domain | CLAT_ADAPTOR_S | 1.25e-03 | 9 | 112 | 2 | PS00989 | |
| Domain | UBA | 1.30e-03 | 36 | 112 | 3 | PF00627 | |
| Domain | ANF_lig-bd_rcpt | 1.41e-03 | 37 | 112 | 3 | IPR001828 | |
| Domain | ANF_receptor | 1.41e-03 | 37 | 112 | 3 | PF01094 | |
| Domain | MAC_perforin | 1.55e-03 | 10 | 112 | 2 | IPR001862 | |
| Domain | Retinoid-X_rcpt/HNF4 | 1.55e-03 | 10 | 112 | 2 | IPR000003 | |
| Domain | Peripla_BP_I | 1.64e-03 | 39 | 112 | 3 | IPR028082 | |
| Domain | AAA | 1.76e-03 | 144 | 112 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.76e-03 | 144 | 112 | 5 | IPR003593 | |
| Domain | MACPF | 1.89e-03 | 11 | 112 | 2 | PF01823 | |
| Domain | Clathrin_sm-chain_CS | 2.26e-03 | 12 | 112 | 2 | IPR000804 | |
| Domain | MACPF | 2.26e-03 | 12 | 112 | 2 | IPR020864 | |
| Domain | MACPF | 2.26e-03 | 12 | 112 | 2 | SM00457 | |
| Domain | UBA | 2.32e-03 | 44 | 112 | 3 | IPR015940 | |
| Domain | IQ | 2.37e-03 | 93 | 112 | 4 | PS50096 | |
| Domain | EF_hand_dom | 2.76e-03 | 232 | 112 | 6 | IPR002048 | |
| Domain | UBA | 2.81e-03 | 47 | 112 | 3 | PS50030 | |
| Domain | ATPase_dyneun-rel_AAA | 3.09e-03 | 14 | 112 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.09e-03 | 14 | 112 | 2 | PF07728 | |
| Domain | AP_mu_sigma_su | 4.05e-03 | 16 | 112 | 2 | IPR022775 | |
| Domain | Acyltransferase | 4.05e-03 | 16 | 112 | 2 | PF01553 | |
| Domain | Clat_adaptor_s | 4.05e-03 | 16 | 112 | 2 | PF01217 | |
| Domain | PlsC | 4.57e-03 | 17 | 112 | 2 | SM00563 | |
| Domain | Plipid/glycerol_acylTrfase | 4.57e-03 | 17 | 112 | 2 | IPR002123 | |
| Domain | Channel_four-helix_dom | 4.85e-03 | 57 | 112 | 3 | IPR027359 | |
| Domain | - | 4.85e-03 | 57 | 112 | 3 | 1.20.120.350 | |
| Domain | P-loop_NTPase | ADCY10 CHST5 KIF27 LRRK2 PEX6 DNAH7 GEM EHD1 MYH15 ASCC3 DNAH9 DNAH11 | 4.88e-03 | 848 | 112 | 12 | IPR027417 |
| Domain | - | 4.90e-03 | 261 | 112 | 6 | 1.10.238.10 | |
| Domain | ZF_ZZ_2 | 5.12e-03 | 18 | 112 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 5.12e-03 | 18 | 112 | 2 | PS01357 | |
| Domain | - | 5.12e-03 | 18 | 112 | 2 | 3.30.70.1230 | |
| Domain | ZZ | 5.12e-03 | 18 | 112 | 2 | PF00569 | |
| Domain | Nucleotide_cyclase | 5.12e-03 | 18 | 112 | 2 | IPR029787 | |
| Domain | Kinase-like_dom | 5.34e-03 | 542 | 112 | 9 | IPR011009 | |
| Domain | Guanylate_cyc | 5.70e-03 | 19 | 112 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 5.70e-03 | 19 | 112 | 2 | PS50125 | |
| Domain | A/G_cyclase | 5.70e-03 | 19 | 112 | 2 | IPR001054 | |
| Domain | Znf_ZZ | 5.70e-03 | 19 | 112 | 2 | IPR000433 | |
| Domain | GUANYLATE_CYCLASE_1 | 5.70e-03 | 19 | 112 | 2 | PS00452 | |
| Domain | CYCc | 5.70e-03 | 19 | 112 | 2 | SM00044 | |
| Domain | ZnF_ZZ | 5.70e-03 | 19 | 112 | 2 | SM00291 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.31e-05 | 47 | 92 | 5 | M42524 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 19284629 | ||
| Pubmed | 9.56e-08 | 68 | 113 | 6 | 14676191 | ||
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 8812438 | ||
| Pubmed | Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease. | 6.63e-07 | 6 | 113 | 3 | 23666762 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.63e-07 | 6 | 113 | 3 | 23652591 | |
| Pubmed | PRMT8 MARK3 BRINP1 GRM1 HSPA12A EHD1 SCN9A MARK2 GABRA1 GABRA5 | 8.78e-07 | 405 | 113 | 10 | 38187761 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CEP85L MARK1 MARK3 RBM42 BARD1 PFAS NUP155 DKC1 PYGL NUP188 MARK2 HERC2 ASCC3 GCN1 UTRN | 9.54e-07 | 1005 | 113 | 15 | 19615732 |
| Pubmed | 1.85e-06 | 8 | 113 | 3 | 21104742 | ||
| Pubmed | 1.85e-06 | 8 | 113 | 3 | 22298430 | ||
| Pubmed | 2.77e-06 | 9 | 113 | 3 | 16382098 | ||
| Pubmed | LPCAT1 MARK1 MARK3 ANO10 SLC7A11 NUP155 EHD1 MACF1 MARK2 CUX1 | 3.13e-06 | 467 | 113 | 10 | 30194290 | |
| Pubmed | 9.33e-06 | 13 | 113 | 3 | 15123669 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25059644 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20346423 | ||
| Pubmed | [Feeling the pressure? Identification of two proteins activated by mechanical forces]. | 1.05e-05 | 2 | 113 | 2 | 21299953 | |
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 1.05e-05 | 2 | 113 | 2 | 11245985 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 34100076 | ||
| Pubmed | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. | 1.05e-05 | 2 | 113 | 2 | 38395992 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 37820892 | ||
| Pubmed | Mechanisms of mechanotransduction and physiological roles of PIEZO channels. | 1.05e-05 | 2 | 113 | 2 | 39251883 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 35581205 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 37975162 | ||
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 1.05e-05 | 2 | 113 | 2 | 23016767 | |
| Pubmed | Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. | 1.05e-05 | 2 | 113 | 2 | 28636944 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 27153334 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 27155990 | ||
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 1.05e-05 | 2 | 113 | 2 | 25172946 | |
| Pubmed | The LisH motif of muskelin is crucial for oligomerization and governs intracellular localization. | 1.05e-05 | 2 | 113 | 2 | 25579817 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25037583 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 31056671 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 16803889 | ||
| Pubmed | The role of PIEZO ion channels in the musculoskeletal system. | 1.05e-05 | 2 | 113 | 2 | 36717101 | |
| Pubmed | Cross Talk Between GH-Regulated Transcription Factors HNF6 and CUX2 in Adult Mouse Liver. | 1.05e-05 | 2 | 113 | 2 | 26218442 | |
| Pubmed | A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel. | 1.05e-05 | 2 | 113 | 2 | 32142647 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 34464353 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20733003 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12524437 | ||
| Pubmed | Cux-1 and Cux-2 control the development of Reelin expressing cortical interneurons. | 1.05e-05 | 2 | 113 | 2 | 18327765 | |
| Pubmed | A unique variant of a homeobox gene related to Drosophila cut is expressed in mouse testis. | 1.05e-05 | 2 | 113 | 2 | 8879483 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19457072 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30324494 | ||
| Pubmed | Expression of a cut-related homeobox gene in developing and polycystic mouse kidney. | 1.05e-05 | 2 | 113 | 2 | 8840273 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22114260 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21056836 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30745454 | ||
| Pubmed | Astrocytes in the optic nerve head express putative mechanosensitive channels. | 1.05e-05 | 2 | 113 | 2 | 26236150 | |
| Pubmed | Touch, Tension, and Transduction - The Function and Regulation of Piezo Ion Channels. | 1.05e-05 | 2 | 113 | 2 | 27743844 | |
| Pubmed | Axonal and Glial PIEZO1 and PIEZO2 Immunoreactivity in Human Clitoral Krause's Corpuscles. | 1.05e-05 | 2 | 113 | 2 | 38928429 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30628892 | ||
| Pubmed | Piezo1 ion channel pore properties are dictated by C-terminal region. | 1.05e-05 | 2 | 113 | 2 | 26008989 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26804994 | ||
| Pubmed | Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. | 1.05e-05 | 2 | 113 | 2 | 20813920 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 16253225 | ||
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 1.17e-05 | 233 | 113 | 7 | 32290105 | |
| Pubmed | LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. | 1.48e-05 | 15 | 113 | 3 | 14976552 | |
| Pubmed | LPCAT1 ACTR8 ADNP2 PEX6 PPFIA3 FMNL2 MACF1 LRRC8B NUP188 CRYBG3 ASCC3 RAPGEF2 ANKS3 WWC1 | 1.62e-05 | 1116 | 113 | 14 | 31753913 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 29655203 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 15193423 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19945424 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 33895391 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 23859570 | ||
| Pubmed | Long-range disruption of gene expression by a selectable marker cassette. | 3.13e-05 | 3 | 113 | 2 | 8917549 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 29521261 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 31680123 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 37321223 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 20025061 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 12610651 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 19699781 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 18784617 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 17566078 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 17544618 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 21145462 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 30726728 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 38124148 | ||
| Pubmed | Multimodal Analysis of STRADA Function in Brain Development. | 3.13e-05 | 3 | 113 | 2 | 32457579 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 16052353 | ||
| Pubmed | PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex. | 3.13e-05 | 3 | 113 | 2 | 30361375 | |
| Pubmed | Piezo1, a mechanically activated ion channel, is required for vascular development in mice. | 3.13e-05 | 3 | 113 | 2 | 24958852 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 14973256 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 9108484 | ||
| Pubmed | PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. | 3.13e-05 | 3 | 113 | 2 | 11433294 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 35650194 | ||
| Pubmed | 3.48e-05 | 493 | 113 | 9 | 15368895 | ||
| Pubmed | Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. | 3.66e-05 | 20 | 113 | 3 | 18227155 | |
| Pubmed | COL4A1 PIEZO1 PKD1L1 LRRK2 ANO10 PIEZO2 TMEM168 CPXM1 NUP188 HERC2 ASCC3 RAPGEF2 UTRN RUBCN | 4.10e-05 | 1215 | 113 | 14 | 15146197 | |
| Pubmed | 5.57e-05 | 653 | 113 | 10 | 22586326 | ||
| Pubmed | 5.64e-05 | 23 | 113 | 3 | 30329130 | ||
| Pubmed | Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. | 6.14e-05 | 65 | 113 | 4 | 23319000 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 8453108 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 17537961 | ||
| Pubmed | Mechanosensory hair cells express two molecularly distinct mechanotransduction channels. | 6.25e-05 | 4 | 113 | 2 | 27893727 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 24402778 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 2040623 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 37074924 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 27411398 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 36563677 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 20529973 | ||
| Pubmed | σ1B adaptin regulates adipogenesis by mediating the sorting of sortilin in adipose tissue. | 6.25e-05 | 4 | 113 | 2 | 24928897 | |
| Pubmed | AP-1/sigma1B-adaptin mediates endosomal synaptic vesicle recycling, learning and memory. | 6.25e-05 | 4 | 113 | 2 | 20203623 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 35801810 | ||
| Interaction | MARK1 interactions | 3.69e-06 | 74 | 113 | 6 | int:MARK1 | |
| Interaction | FUCA1 interactions | 1.49e-05 | 27 | 113 | 4 | int:FUCA1 | |
| Cytoband | 6q24 | 1.64e-04 | 8 | 112 | 2 | 6q24 | |
| Cytoband | 2q24 | 3.20e-04 | 11 | 112 | 2 | 2q24 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.41e-06 | 9 | 82 | 3 | 1203 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 7.41e-06 | 9 | 82 | 3 | 527 | |
| GeneFamily | Dyneins, axonemal | 5.84e-05 | 17 | 82 | 3 | 536 | |
| GeneFamily | Glycogen phosphorylases | 6.08e-05 | 3 | 82 | 2 | 437 | |
| GeneFamily | EF-hand domain containing | 4.80e-04 | 219 | 82 | 6 | 863 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.97e-03 | 18 | 82 | 2 | 91 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.30e-03 | 19 | 82 | 2 | 563 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_UP | 5.94e-07 | 166 | 112 | 8 | M12595 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SOX11 CEP85L MARK1 LRRK2 GRIK2 GRM1 FMNL2 CASZ1 HSPA12A PIEZO2 ST3GAL5 SCN2A SCN3A SCN9A AP1S2 MDGA1 WNK3 GABRA1 | 1.04e-06 | 1106 | 112 | 18 | M39071 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_UP | 1.46e-06 | 187 | 112 | 8 | MM1034 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP | 2.27e-05 | 197 | 112 | 7 | M9589 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OTOA SOX11 EFCAB6 GRM1 RYR3 PIEZO2 SCN2A SCN9A MYH15 USH2A DNAH9 DNAH11 | 4.71e-14 | 184 | 112 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OTOA SOX11 EFCAB6 GRM1 RYR3 PIEZO2 SCN2A SCN9A MYH15 USH2A DNAH9 DNAH11 | 4.71e-14 | 184 | 112 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OTOA SOX11 EFCAB6 GRM1 RYR3 PIEZO2 SCN2A SCN9A MYH15 USH2A DNAH9 DNAH11 | 4.71e-14 | 184 | 112 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-09 | 200 | 112 | 9 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-09 | 200 | 112 | 9 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-07 | 169 | 112 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-07 | 180 | 112 | 7 | a407376209d80177bf7fc4200219030c83cb5f14 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-07 | 184 | 112 | 7 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-07 | 190 | 112 | 7 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.94e-07 | 193 | 112 | 7 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.36e-07 | 195 | 112 | 7 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.81e-07 | 197 | 112 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.54e-07 | 200 | 112 | 7 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.54e-07 | 200 | 112 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Myeloid-Myeloid-F|Myeloid / shred on cell class and cell subclass (v4) | 2.79e-06 | 156 | 112 | 6 | d6317843ae5c5749452889e768c187a9d9e8c7fe | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 5.77e-06 | 177 | 112 | 6 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.96e-06 | 178 | 112 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-06 | 181 | 112 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.56e-06 | 181 | 112 | 6 | cb17c904ab86d56dd30cac9b61acbb3b76f84ded | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.56e-06 | 181 | 112 | 6 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.56e-06 | 181 | 112 | 6 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 184 | 112 | 6 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.43e-06 | 185 | 112 | 6 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.43e-06 | 185 | 112 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-06 | 185 | 112 | 6 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.66e-06 | 186 | 112 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.66e-06 | 186 | 112 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.66e-06 | 186 | 112 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 187 | 112 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.39e-06 | 189 | 112 | 6 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.39e-06 | 189 | 112 | 6 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-06 | 190 | 112 | 6 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 8.91e-06 | 191 | 112 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.18e-06 | 192 | 112 | 6 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 193 | 112 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 193 | 112 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-06 | 194 | 112 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.74e-06 | 194 | 112 | 6 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.00e-05 | 195 | 112 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.00e-05 | 195 | 112 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.06e-05 | 197 | 112 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.06e-05 | 197 | 112 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-05 | 197 | 112 | 6 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-05 | 197 | 112 | 6 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.16e-05 | 200 | 112 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.16e-05 | 200 | 112 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.51e-05 | 137 | 112 | 5 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 140 | 112 | 5 | 7ca49bd7ba9381e75c10f888775df17e5d46804d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 140 | 112 | 5 | 1a31bc33d5723b9bc528cc0047ca5f4c80531c7a | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-05 | 143 | 112 | 5 | 8f82b3c3331f20c6ded36dbfb9a48dbd9f099f93 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-05 | 143 | 112 | 5 | 52832321cc848739ff6483f467d57c50c8b7395c | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-05 | 148 | 112 | 5 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-05 | 148 | 112 | 5 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.76e-05 | 149 | 112 | 5 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.26e-05 | 153 | 112 | 5 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.68e-05 | 156 | 112 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.27e-05 | 160 | 112 | 5 | 731def6d82814ebac1a400bc7aea5f6da43ec960 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 160 | 112 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.27e-05 | 160 | 112 | 5 | cf27b4ac4d0caa6f9b068dc8ea93472470a01a4d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 160 | 112 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 6.28e-05 | 166 | 112 | 5 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.28e-05 | 166 | 112 | 5 | 9e916fc1858573358e1eb5e3789b2c9f8ef74476 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.03e-05 | 170 | 112 | 5 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-05 | 171 | 112 | 5 | 8a0c08f0aa3a80cd6346c81deb242e430ebd897b | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 7.43e-05 | 172 | 112 | 5 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 172 | 112 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | CTRL-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 7.84e-05 | 174 | 112 | 5 | ff4315e9fad198cc323fc987deb8652da137cf98 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.06e-05 | 175 | 112 | 5 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.06e-05 | 175 | 112 | 5 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.50e-05 | 177 | 112 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.50e-05 | 177 | 112 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.50e-05 | 177 | 112 | 5 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 8.50e-05 | 177 | 112 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.50e-05 | 177 | 112 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.50e-05 | 177 | 112 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.73e-05 | 178 | 112 | 5 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.73e-05 | 178 | 112 | 5 | 982205ba117a4c7b7e9b713689a5b69190f0bca9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.96e-05 | 179 | 112 | 5 | 466da2bc3bfc534ffe111c8c28ece7a3cfa08051 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.96e-05 | 179 | 112 | 5 | f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-pDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.96e-05 | 179 | 112 | 5 | bbd4f8e988ef3f343aaedbc992b70f2bb6aff5f6 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 8.96e-05 | 179 | 112 | 5 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.69e-05 | 182 | 112 | 5 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 9.69e-05 | 182 | 112 | 5 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.69e-05 | 182 | 112 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.94e-05 | 183 | 112 | 5 | cfbf8539104cef9ca830ad4f6bb278746f7078f7 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.94e-05 | 183 | 112 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.94e-05 | 183 | 112 | 5 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.94e-05 | 183 | 112 | 5 | f142b320023eef00b48d4820c46214c9794d37e7 | |
| ToppCell | cellseq2-Immune-Hematopoietic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.94e-05 | 183 | 112 | 5 | 324ec4374b552da7ce03809945b3a0798342d4ba | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 184 | 112 | 5 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 184 | 112 | 5 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 184 | 112 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 1.02e-04 | 184 | 112 | 5 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 1.02e-04 | 184 | 112 | 5 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 185 | 112 | 5 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-04 | 185 | 112 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.05e-04 | 185 | 112 | 5 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 185 | 112 | 5 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 185 | 112 | 5 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 185 | 112 | 5 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 6.02e-07 | 198 | 112 | 9 | 4956_UP | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 4.43e-06 | 189 | 112 | 8 | 7206_UP | |
| Drug | propofol | 4.78e-06 | 191 | 112 | 8 | CID000004943 | |
| Drug | meprobamate | 4.83e-06 | 88 | 112 | 6 | CID000004064 | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; HL60; HG-U133A | 5.37e-06 | 194 | 112 | 8 | 1369_DN | |
| Drug | Secobarbital | 1.36e-05 | 10 | 112 | 3 | DB00418 | |
| Drug | Metharbital | 1.36e-05 | 10 | 112 | 3 | DB00463 | |
| Drug | Pentobarbital | 1.36e-05 | 10 | 112 | 3 | DB00312 | |
| Drug | Talbutal | 1.36e-05 | 10 | 112 | 3 | DB00306 | |
| Drug | Butalbital | 1.36e-05 | 10 | 112 | 3 | DB00241 | |
| Drug | Butabarbital | 1.36e-05 | 10 | 112 | 3 | DB00237 | |
| Drug | Barbituric acid derivative | 1.36e-05 | 10 | 112 | 3 | DB01496 | |
| Drug | Barbital | 1.36e-05 | 10 | 112 | 3 | DB01483 | |
| Drug | Hexobarbital | 1.36e-05 | 10 | 112 | 3 | DB01355 | |
| Drug | Aprobarbital | 1.36e-05 | 10 | 112 | 3 | DB01352 | |
| Drug | Amobarbital | 1.36e-05 | 10 | 112 | 3 | DB01351 | |
| Drug | Heptabarbital | 1.36e-05 | 10 | 112 | 3 | DB01354 | |
| Drug | Butethal | 1.36e-05 | 10 | 112 | 3 | DB01353 | |
| Drug | Methylphenobarbital | 1.36e-05 | 10 | 112 | 3 | DB00849 | |
| Drug | Primidone | 1.36e-05 | 10 | 112 | 3 | DB00794 | |
| Drug | octopamine | 1.66e-05 | 109 | 112 | 6 | CID000004581 | |
| Drug | phenformin | 1.79e-05 | 32 | 112 | 4 | CID000008249 | |
| Drug | Thiopental | 1.86e-05 | 11 | 112 | 3 | DB00599 | |
| Drug | Phenobarbital | 1.86e-05 | 11 | 112 | 3 | DB01174 | |
| Drug | 5-(2-chloroethyl)uracil | 2.40e-05 | 2 | 112 | 2 | CID010442204 | |
| Drug | 6878P | 2.40e-05 | 2 | 112 | 2 | CID002725013 | |
| Drug | AC1LBRFU | 2.40e-05 | 2 | 112 | 2 | CID000562981 | |
| Drug | AC1L19D1 | 2.47e-05 | 12 | 112 | 3 | CID000000494 | |
| Drug | riluzole | 2.49e-05 | 174 | 112 | 7 | CID000005070 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 3.23e-05 | 37 | 112 | 4 | CID000009643 | |
| Drug | celecoxib; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 4.22e-05 | 189 | 112 | 7 | 922_UP | |
| Drug | aniracetam | 4.50e-05 | 130 | 112 | 6 | CID000002196 | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.52e-05 | 191 | 112 | 7 | 3377_UP | |
| Drug | ketamine | 4.68e-05 | 262 | 112 | 8 | CID000003821 | |
| Drug | Gvapspat amide | 5.05e-05 | 15 | 112 | 3 | CID000125015 | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 1289_UP | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 6435_UP | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 2749_UP | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 5245_UP | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 5.85e-05 | 199 | 112 | 7 | 5687_UP | |
| Drug | Sodium | 5.97e-05 | 84 | 112 | 5 | ctd:D012964 | |
| Drug | Sodium thioglucse | 6.19e-05 | 16 | 112 | 3 | CID000151466 | |
| Drug | 5-methylthioribose-1-phosphate | 6.19e-05 | 16 | 112 | 3 | CID000000465 | |
| Drug | 3,5-dimethylphenyl isocyanate | 7.17e-05 | 3 | 112 | 2 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 7.17e-05 | 3 | 112 | 2 | CID000147839 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 7.17e-05 | 3 | 112 | 2 | ctd:C561228 | |
| Drug | NSC758405 | 7.17e-05 | 3 | 112 | 2 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 7.17e-05 | 3 | 112 | 2 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 7.17e-05 | 3 | 112 | 2 | CID000196007 | |
| Drug | Aspaminol | 7.17e-05 | 3 | 112 | 2 | CID003084278 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 7.17e-05 | 3 | 112 | 2 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 7.17e-05 | 3 | 112 | 2 | CID000191554 | |
| Drug | hydan | 7.17e-05 | 3 | 112 | 2 | CID000008360 | |
| Drug | EHMF | 7.17e-05 | 3 | 112 | 2 | CID000033931 | |
| Drug | AC1L29EX | 7.17e-05 | 3 | 112 | 2 | CID000043221 | |
| Drug | pyridoxal 5'-methylenephosphonate | 7.17e-05 | 3 | 112 | 2 | CID003082249 | |
| Drug | Plp 5'-mpa | 7.17e-05 | 3 | 112 | 2 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 7.17e-05 | 3 | 112 | 2 | CID000191723 | |
| Drug | 3'-FFdUrd | 7.17e-05 | 3 | 112 | 2 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 7.17e-05 | 3 | 112 | 2 | CID000119518 | |
| Drug | AC1L8XK3 | 7.17e-05 | 3 | 112 | 2 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 7.17e-05 | 3 | 112 | 2 | CID000446801 | |
| Drug | riboflavin tetraacetate | 7.17e-05 | 3 | 112 | 2 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 7.17e-05 | 3 | 112 | 2 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 7.17e-05 | 3 | 112 | 2 | CID000011459 | |
| Drug | Zonisamide | 7.49e-05 | 17 | 112 | 3 | DB00909 | |
| Drug | Scorpion Venoms | 8.96e-05 | 18 | 112 | 3 | ctd:D012604 | |
| Drug | pentobarbital | 1.23e-04 | 224 | 112 | 7 | CID000004737 | |
| Drug | sulfacetamide | 1.35e-04 | 53 | 112 | 4 | CID000005320 | |
| Drug | galocitabine | 1.43e-04 | 4 | 112 | 2 | CID000065950 | |
| Drug | rhenium sulfide | 1.43e-04 | 4 | 112 | 2 | CID000159414 | |
| Drug | 5-deoxyribose-1-phosphate | 1.43e-04 | 4 | 112 | 2 | CID000135786 | |
| Drug | Flumazenil | 1.43e-04 | 4 | 112 | 2 | DB01205 | |
| Drug | ingliforib | 1.43e-04 | 4 | 112 | 2 | CID006451325 | |
| Drug | uric acid riboside | 1.43e-04 | 4 | 112 | 2 | CID000164933 | |
| Drug | pseudo-dl-glucose | 1.43e-04 | 4 | 112 | 2 | CID000125259 | |
| Drug | perfluorohexanoic acid | 1.43e-04 | 4 | 112 | 2 | CID000067542 | |
| Drug | pyridoxal diphosphate | 1.43e-04 | 4 | 112 | 2 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 1.43e-04 | 4 | 112 | 2 | CID000189134 | |
| Drug | AC1LAMW2 | 1.43e-04 | 4 | 112 | 2 | CID000491364 | |
| Drug | FdUrd-C8 | 1.43e-04 | 4 | 112 | 2 | CID000094262 | |
| Drug | Mem-CC | 1.43e-04 | 4 | 112 | 2 | CID003081269 | |
| Drug | 2H-5a | 1.43e-04 | 4 | 112 | 2 | CID000440102 | |
| Drug | BCIp4A | 1.43e-04 | 4 | 112 | 2 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 1.43e-04 | 4 | 112 | 2 | CID000097703 | |
| Drug | AC1L9JWW | 1.44e-04 | 21 | 112 | 3 | CID000446637 | |
| Drug | gabapentin | 1.91e-04 | 169 | 112 | 6 | CID000003446 | |
| Drug | thiopental | 2.32e-04 | 112 | 112 | 5 | CID003000715 | |
| Drug | heptulose-2-P | 2.38e-04 | 5 | 112 | 2 | CID000124823 | |
| Drug | 6-FPLP | 2.38e-04 | 5 | 112 | 2 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 2.38e-04 | 5 | 112 | 2 | CID009576855 | |
| Drug | Eszopiclone | 2.38e-04 | 5 | 112 | 2 | DB00402 | |
| Drug | DHPBU | 2.38e-04 | 5 | 112 | 2 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 2.38e-04 | 5 | 112 | 2 | CID003080910 | |
| Drug | AC1L1DX8 | 2.38e-04 | 5 | 112 | 2 | CID000002546 | |
| Drug | Zopiclone | 2.38e-04 | 5 | 112 | 2 | DB01198 | |
| Drug | indirubin-5-sulphonate | 2.38e-04 | 5 | 112 | 2 | CID005288641 | |
| Drug | VaraU | 2.38e-04 | 5 | 112 | 2 | CID000126501 | |
| Drug | AC1LCUXJ | 2.38e-04 | 5 | 112 | 2 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 2.38e-04 | 5 | 112 | 2 | CID000080578 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.18e-07 | 13 | 108 | 4 | C0751122 | |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 1.90e-07 | 4 | 108 | 3 | DOID:0070356 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.62e-06 | 10 | 108 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.62e-06 | 10 | 108 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Situs Inversus | 7.70e-06 | 11 | 108 | 3 | C0037221 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.02e-05 | 12 | 108 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 3.97e-05 | 3 | 108 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 3.97e-05 | 3 | 108 | 2 | 614519 | |
| Disease | anxiety disorder (implicated_via_orthology) | 6.98e-05 | 22 | 108 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | Schizophrenia | ADNP2 GRIK2 GRM1 ACE ADAM12 HSPA12A NR2E1 MARK2 MDGA1 WNK3 GABRA1 GABRA5 | 9.61e-05 | 883 | 108 | 12 | C0036341 |
| Disease | Disorder of eye | 1.33e-04 | 212 | 108 | 6 | C0015397 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.99e-04 | 145 | 108 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 2 | 2.63e-04 | 34 | 108 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 2.63e-04 | 34 | 108 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 2.63e-04 | 34 | 108 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 2.63e-04 | 34 | 108 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 2.63e-04 | 34 | 108 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 2.63e-04 | 34 | 108 | 3 | C0087012 | |
| Disease | unipolar depression, bipolar disorder | 2.79e-04 | 156 | 108 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Spinocerebellar Ataxia Type 4 | 2.87e-04 | 35 | 108 | 3 | C0752122 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.94e-04 | 713 | 108 | 10 | EFO_0005689 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 3.66e-04 | 8 | 108 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 3.66e-04 | 8 | 108 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 3.66e-04 | 8 | 108 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 3.66e-04 | 8 | 108 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 3.66e-04 | 8 | 108 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 3.66e-04 | 8 | 108 | 2 | C0393703 | |
| Disease | Bipolar Disorder | 3.78e-04 | 477 | 108 | 8 | C0005586 | |
| Disease | Myoclonic Epilepsy | 4.70e-04 | 9 | 108 | 2 | C0014550 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 4.70e-04 | 9 | 108 | 2 | C3502809 | |
| Disease | Situs ambiguous | 4.70e-04 | 9 | 108 | 2 | C1167664 | |
| Disease | sodium measurement | 5.68e-04 | 103 | 108 | 4 | EFO_0009282 | |
| Disease | Epilepsy, Myoclonic, Infantile | 5.86e-04 | 10 | 108 | 2 | C0917800 | |
| Disease | Malignant neoplasm of salivary gland | 6.05e-04 | 45 | 108 | 3 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 6.88e-04 | 47 | 108 | 3 | C0036095 | |
| Disease | Myoclonic Astatic Epilepsy | 7.14e-04 | 11 | 108 | 2 | C0393702 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 8.59e-04 | 115 | 108 | 4 | EFO_0007878, EFO_0010724 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.01e-03 | 13 | 108 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | bilirubin measurement | 1.23e-03 | 442 | 108 | 7 | EFO_0004570 | |
| Disease | Situs ambiguus | 1.35e-03 | 15 | 108 | 2 | C0266642 | |
| Disease | cathepsin L1 measurement | 1.54e-03 | 16 | 108 | 2 | EFO_0010619 | |
| Disease | Cerebrovascular accident | 1.54e-03 | 62 | 108 | 3 | C0038454 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 1.64e-03 | 137 | 108 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | colorectal cancer | 1.73e-03 | 604 | 108 | 8 | MONDO_0005575 | |
| Disease | phosphatidylcholine 40:6 measurement | 1.74e-03 | 17 | 108 | 2 | EFO_0010389 | |
| Disease | lateral occipital cortex volume measurement | 1.74e-03 | 17 | 108 | 2 | EFO_0010311 | |
| Disease | MHPG measurement, 5-HIAA measurement | 1.74e-03 | 17 | 108 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | aspartate aminotransferase measurement | CUX2 KIF27 MARK3 SLC26A2 PIEZO1 GPAM RGL1 HSPA12A ADAMTS9 GCN1 | 1.80e-03 | 904 | 108 | 10 | EFO_0004736 |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.93e-03 | 67 | 108 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | squamous cell carcinoma | 1.93e-03 | 67 | 108 | 3 | EFO_0000707 | |
| Disease | acetate measurement | 2.42e-03 | 20 | 108 | 2 | EFO_0010112 | |
| Disease | alpha-tocopherol measurement | 2.42e-03 | 20 | 108 | 2 | EFO_0007898 | |
| Disease | COVID-19 (is_implicated_in) | 2.66e-03 | 21 | 108 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | cerebellar cortex volume measurement | 2.66e-03 | 21 | 108 | 2 | EFO_0010291 | |
| Disease | Autistic Disorder | 2.77e-03 | 261 | 108 | 5 | C0004352 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.19e-03 | 23 | 108 | 2 | C1335177 | |
| Disease | phosphatidylserines measurement | 3.19e-03 | 23 | 108 | 2 | EFO_0020049 | |
| Disease | Coronary heart disease | 3.48e-03 | 24 | 108 | 2 | C0010068 | |
| Disease | amino acid measurement | 3.51e-03 | 678 | 108 | 8 | EFO_0005134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHRKRKMAAWPFSRL | 11 | P04003 | |
| NSIKMWFSPRSKKVR | 141 | Q99728 | |
| FSRWKTIGSLRPMKQ | 2821 | Q68DQ2 | |
| FDPRWRKRMSLTLKS | 516 | O60477 | |
| LKQGWTPRRMFKEAD | 911 | P12821 | |
| KRFWIIEDMSPFGKR | 1401 | Q86V15 | |
| AIWSKKMSNGTRRIP | 116 | Q9H981 | |
| WHKLSLKGREPFVRM | 1171 | P39880 | |
| KVSHFLPWIKRTMKR | 231 | P20718 | |
| ARKPKMCSFLEWRDL | 41 | P61966 | |
| AVIKWMKRIPFVLSA | 481 | Q96SM3 | |
| RVPKDRSWKAAKVFM | 3231 | Q96DT5 | |
| FLDWRKMKLLPRKSH | 286 | O43184 | |
| MLNTVIFARDKWLKP | 196 | Q9NR22 | |
| SERPWIKRMIFKLFS | 336 | Q9HDC9 | |
| STSWRFMEKLIRTLP | 651 | Q96PN6 | |
| YAKKLWTAPELLRMA | 696 | P16066 | |
| REKMLSRFGRFWKKP | 76 | O95813 | |
| WSKLTQKGREPFIRM | 941 | O14529 | |
| APFLKWMREKTVRCL | 736 | Q6IQ32 | |
| FWLATIERSEMFKKP | 1631 | P02462 | |
| YVGSRPIKLRKSMWK | 446 | Q9BTD8 | |
| RLLFMAVKWAKNLPV | 226 | Q9Y5X4 | |
| YRLKKTWAAVPRDRM | 341 | Q9NZL6 | |
| PLSWNVAVKFLMARK | 41 | P43378 | |
| SMPRKARRFWGKIVA | 261 | P55040 | |
| RWGTLLMKRKFEEPR | 271 | Q9NW15 | |
| RKPKMCSFLEWRDLK | 41 | P56377 | |
| WFKNGKPARMSKRLL | 371 | Q8NFP4 | |
| SKMARTLPTKEFLWA | 791 | Q7RTW8 | |
| WRKVVDFLLKAIMRT | 91 | Q8NF37 | |
| TWLDFAMAVKRDSRK | 2156 | Q14667 | |
| FAKLCTMVAPKLRSW | 86 | Q9HCP6 | |
| FLWGPRARAETSKMK | 271 | A8MXT2 | |
| WGPRARLETSKMKAL | 901 | Q9HCI5 | |
| LKEMRFISPRKWTQG | 351 | Q8IX03 | |
| MSKFKLLSSLPRWRR | 1531 | O95714 | |
| AKSFSRSPSWRKMFR | 1121 | O75145 | |
| MTKAADPRFRPRWKV | 31 | Q8WVQ1 | |
| LKWASRPESMKLSGR | 1261 | Q86VH2 | |
| SPEKLPRWREMFFKV | 371 | Q13608 | |
| PRWREMFFKVKKTVG | 376 | Q13608 | |
| PWSKLKSGRETFRRM | 336 | Q9UBC0 | |
| MKPWLFNIKARASSS | 1431 | Q5S007 | |
| SWKDERLKFKGPMTV | 96 | P14867 | |
| RQSWKDERLRFKGPM | 101 | P31644 | |
| RFTMEVPKKLTEWFK | 416 | Q92616 | |
| FKIKRPAAWVDLMIA | 371 | O43301 | |
| MLSSFPHRKTWRKSK | 1 | Q96KD3 | |
| ILRLKFTEMGKIPRW | 491 | Q6P9F7 | |
| STSWFRKPMTRAELV | 561 | Q9UPN3 | |
| LFKSRDPFWNRMKKP | 1306 | O75694 | |
| VRWVPKYSGILMKDR | 671 | Q9P2N4 | |
| SIKPSTMWFGERSRK | 286 | Q96SD1 | |
| KIVHCWRPMRRTFKS | 1431 | Q5THR3 | |
| LKPVRTAAKTTWFIM | 281 | P51810 | |
| RAEMEILPKPWRKSF | 246 | Q8WXX0 | |
| VVWMRTAALPTFRKL | 251 | Q3MIR4 | |
| DMKDFRPLRKWSSLS | 146 | Q5SZL2 | |
| NKWRSRRKMLTPTFH | 141 | Q6ZWL3 | |
| KTKFRMPVFNWVALK | 621 | Q96PY5 | |
| KPRSLRFTWSMKTTS | 696 | Q9P0L2 | |
| REAKPRSLRFTWSMK | 686 | Q7KZI7 | |
| KEAKPRSLRFTWSMK | 651 | P27448 | |
| LFGPKRKMTSAIARW | 471 | Q6ZW76 | |
| PWIRTTMRSFKLLDQ | 236 | P08311 | |
| KTYQIMKRRPVWTDL | 2166 | Q9NYC9 | |
| RVPKDRSWKAAKVTM | 3201 | Q9NYC9 | |
| WIDRSMKTRGLPKAK | 461 | P00742 | |
| KPWRFGTRFMSLIKE | 351 | Q13002 | |
| KKICTRKPRFMSAWA | 691 | Q13255 | |
| EMKWRKVCPSSRSLS | 206 | Q8IUY3 | |
| IKRVIMERDTYPRKW | 366 | O60832 | |
| MFSWVSKDARRKKEP | 1 | Q9H4M9 | |
| MAIPSRVLRKWDFSK | 756 | Q92622 | |
| MWEKVLTFLRLETPK | 2761 | Q8TDX9 | |
| RLLFMSIKWAKSVPA | 191 | Q9Y466 | |
| RWKMLKDSEKIPFIR | 86 | P35716 | |
| MRFIDKTSALSPWTK | 2681 | O75445 | |
| LFSWDKVVKMSPIER | 196 | P46939 | |
| MSFLVSKPERIRRWV | 1 | Q7RTN6 | |
| SYWIRTSKPVFRKML | 146 | Q9H061 | |
| PKMRLDDFWSLKLCR | 611 | Q9UL63 | |
| WMRLFFKIKPLVKSS | 841 | Q9Y2K3 | |
| WKESLMSRKRPFVGR | 51 | Q9HCL2 | |
| LKKIMRTEGFWRPLR | 91 | Q9NYZ2 | |
| RVFKLAKSWPTLNML | 841 | Q15858 | |
| AMVKKETLPFWVRLF | 276 | Q9UNP4 | |
| RRSWLMAKCAVPKSD | 786 | Q6ZUB1 | |
| LRVFKLAKSWPTLNM | 856 | Q9NY46 | |
| LKSLMARRTYLEWPK | 746 | Q15399 | |
| WFDPSWRKRMLLTLK | 541 | Q9C0B6 | |
| RALFEIALRKRWPTM | 1091 | Q8N3C0 | |
| RMWLPRFSSKTVTVL | 21 | Q9GZS9 | |
| FSKLNPRKIIRMWAE | 316 | O14730 | |
| RTFMIKFPWKLTDAI | 651 | Q96JI7 | |
| DPALMFRTRKKKWRS | 916 | Q9Y4G8 | |
| DKKPRWFRIMSEKIT | 471 | Q9UPY5 | |
| DKSKSSFLIMWRRPE | 91 | Q9BRG1 | |
| KTFNWPISLRKHMRT | 431 | Q8NEP9 | |
| QPFAMKSWLRDVLRK | 76 | Q9NZQ8 | |
| LRGALRKFRDLPKMW | 491 | P50443 | |
| RDVAMWFSKRLPTFV | 1231 | Q15413 | |
| WVLGKMPRKEFFLQR | 631 | O15067 | |
| RVFKLAKSWPTLNML | 856 | Q99250 | |
| RWMEIKIRSPRFIDF | 156 | Q9GZP7 | |
| LYRSPETMIKWTREK | 2736 | Q9H5I5 | |
| TMRLWSAKAPNDFKL | 241 | P11216 | |
| RDSAMLVLRTKPKFW | 996 | Q5SRE5 | |
| RCLKRLKMSWFLPTV | 671 | Q9H0V1 | |
| LYRSPETMIKWTREK | 2506 | Q92508 | |
| FLKMTTWILPKITRR | 446 | Q9WJR5 | |
| MRIFVDIEKLPWSKA | 351 | P06737 | |
| MRKTWRRFEVPTSKS | 191 | Q9H2S5 | |
| RFKVMKPKVLRSWCR | 241 | Q9BYP7 | |
| RWTRPSLDFLKMTQT | 281 | Q6NSI3 |